STRICTLY CONFIDENTIAL CEL-SCI CorporationLetter Agreement • August 24th, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 24th, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIALLetter Agreement • June 5th, 2017 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 5th, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL Medical Transcription Billing Corp.Letter Agreement • June 2nd, 2017 • Medical Transcription Billing, Corp • Services-prepackaged software • New York
Contract Type FiledJune 2nd, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL Medical Transcription Billing Corp.Letter Agreement • May 12th, 2017 • Medical Transcription Billing, Corp • Services-prepackaged software • New York
Contract Type FiledMay 12th, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL Ms. Kathleen Valiasek Chief Financial Officer Amyris, Inc.Letter Agreement • May 8th, 2017 • Amyris, Inc. • Industrial organic chemicals • New York
Contract Type FiledMay 8th, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL Alphatec Holdings, Inc.Letter Agreement • March 23rd, 2017 • Alphatec Holdings, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 23rd, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL CEL-SCI CorporationLetter Agreement • March 10th, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 10th, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL XTL Biopharmaceuticals Ltd.Letter Agreement • February 22nd, 2017 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledFebruary 22nd, 2017 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL CEL-SCI CorporationLetter Agreement • February 21st, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 21st, 2017 Company Industry Jurisdiction
January 13, 2017 STRICTLY CONFIDENTIAL Hemispherx BioPharma, Inc.Letter Agreement • February 3rd, 2017 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 3rd, 2017 Company Industry Jurisdiction
December 12, 2016Letter Agreement • December 14th, 2016 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 14th, 2016 Company Industry JurisdictionThis letter agreement (this “Agreement”) constitutes the agreement between CytRx Corporation (the “Company”) and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC (“Rodman”), that Rodman shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (“Securities”) during the Term (as defined below) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Rodman and nothing herein implies that Rodman would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Rodman’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Rodman deems appropriate under the circumstances and to the receipt of all internal approvals of Rodman in connection wi
STRICTLY CONFIDENTIAL Mr. Nadir Ali Chief Executive Officer Sysorex Global Holdings Corp.Letter Agreement • December 12th, 2016 • Sysorex Global • Services-computer programming services • New York
Contract Type FiledDecember 12th, 2016 Company Industry Jurisdiction
September 24, 2016Letter Agreement • September 27th, 2016 • BioPharmX Corp • Pharmaceutical preparations • New York
Contract Type FiledSeptember 27th, 2016 Company Industry Jurisdiction
September 9, 2016Letter Agreement • September 9th, 2016 • Cancer Genetics, Inc • Services-medical laboratories • New York
Contract Type FiledSeptember 9th, 2016 Company Industry Jurisdiction
August 26, 2016 STRICTLY CONFIDENTIAL Hemispherx BioPharma, Inc.Letter Agreement • September 1st, 2016 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 1st, 2016 Company Industry Jurisdiction
STRICTLY CONFIDENTIAL Cel-Sci CorporationLetter Agreement • August 24th, 2016 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 24th, 2016 Company Industry Jurisdiction
June 24, 2016Letter Agreement • August 9th, 2016 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2016 Company Industry Jurisdiction
July 29, 2016Letter Agreement • August 1st, 2016 • Evoke Pharma Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 1st, 2016 Company Industry Jurisdiction
July 19, 2016Letter Agreement • July 20th, 2016 • Evoke Pharma Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 20th, 2016 Company Industry Jurisdiction
July 14, 2016Letter Agreement • July 15th, 2016 • Cytrx Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 15th, 2016 Company Industry JurisdictionThis letter agreement (this “Agreement”) constitutes the agreement between CytRx Corporation (the “Company”) and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC (“Rodman”), that Rodman shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (“Securities”) during the Term (as defined below) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Rodman and nothing herein implies that Rodman would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Rodman’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Rodman deems appropriate under the circumstances and to the receipt of all internal approvals of Rodman in connection wi
June 24, 2016 STRICTLY CONFIDENTIAL Stephen From President and Chief Executive Officer EyeGate Pharmaceuticals, Inc.Letter Agreement • June 27th, 2016 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 27th, 2016 Company Industry Jurisdiction
May 15, 2016 STRICTLY CONFIDENTIAL Biostage, Inc.Letter Agreement • May 16th, 2016 • Biostage, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 16th, 2016 Company Industry Jurisdiction
May 4, 2016Letter Agreement • May 10th, 2016 • Genvec Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2016 Company Industry Jurisdiction